NCT00092820View on ClinicalTrials.gov

Sitosterolemia Extension Study (0653-004)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 12, 2001

Primary Completion Date

September 18, 2001

Study Completion Date

November 30, 2004

Conditions
Lipid Metabolism, Inborn ErrorsHeart Disease
Interventions
DRUG

MK0653, ezetimibe

DRUG

Comparator: placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092820 - Sitosterolemia Extension Study (0653-004)(COMPLETED) | Biotech Hunter | Biotech Hunter